A niche opportunity for stem cell therapeutics

Gene Therapy

Volumn 15, Issue 2, 2008, Pages 96-99

  Adams, G B ^a   Scadden, D T ^b,c  

^a UNIVERSITY OF SOUTHERN CALIFORNIA   (United States)

^b HARVARD MEDICAL SCHOOL   (United States)

^c HARVARD STEM CELL INSTITUTE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

COLLAGEN TYPE 1; HERMES ANTIGEN; HYALURONIC ACID; PARATHYROID HORMONE; RECOMBINANT PARATHYROID HORMONE;

BONE MARROW TRANSPLANTATION; CANCER STEM CELL; CELL COUNT; CELL DIFFERENTIATION; CELL FUNCTION; CELL HOMING; CELL INTERACTION; CELL MANIPULATION; CELL POPULATION; CELL RENEWAL; CELLULAR DISTRIBUTION; DRUG TARGETING; HEMATOPOIETIC STEM CELL; HEMATOPOIETIC STEM CELL TRANSPLANTATION; HUMAN; NONHUMAN; OSTEOBLAST; PRIORITY JOURNAL; REVIEW; STEM CELL GENE THERAPY; TARGET CELL;

CELL MOVEMENT; HEMATOPOIETIC STEM CELLS; HUMANS; NEOPLASMS; NEOVASCULARIZATION, PATHOLOGIC; OSTEOGENESIS; PARATHYROID HORMONE; REGENERATIVE MEDICINE; STEM CELL TRANSPLANTATION;

EID: 37749024280     PISSN: 09697128     EISSN: 14765462     Source Type: Journal    
DOI: 10.1038/sj.gt.3303063     Document Type: Review

References (29)

1. Nathwani AC, Davidoff AM, Linch DC. A review of gene therapy for haematological disorders. Br J Haematol 2004; 128: 3-17.
2. Cavazzana-Calvo M, Hacein-Bey S, de Saint Basile G, Gross F, Yvon E, Nusbaum P et al. Gene therapy of human severe combined immunodeficiency (SCID)-X1 disease. Science 2000; 288: 669-672.
3. Mikkola HKA, Orkin SH. The journey of developing hematopoietic stem cells. Development 2006; 133: 3733-3744.
4. Lord BI, Testa NG, Hendry JH. The relative spatial distributions of CFUs and CFUc in the normal mouse femur. Blood 1975; 46: 65-72.
5. Nilsson SK, Johnston HM, Coverdale JA. Spatial localization of transplanted hemopoietic stem cells: Inferences for the localization of stem cell niches. Blood 2001; 97: 2293-2299.
6. Schofield R. The relationship between the spleen colony-forming cell and the haemopoietic stem cell. Blood Cells 1978; 4: 7-25.
7. Schofield R. The stem cell system. Biomed Pharmacother 1983; 37 375-380.
8. Taichman RS, Emerson SG. Human osteoblasts support hematopoiesis through the production of granulocyte colony-stimulating factor. J Exp Med 1994; 179: 1677-1682.
9. Blair HC, Julian BA, Cao X, Jordan SE, Dong SS. Parathyroid hormone-regulated production of stem cell factor in human osteoblasts and osteoblast-like cells. Biochem Biophys Res Comm 1999; 255 778-784.
10. Taichman RS, Reilly MJ, Emerson SG. Human osteoblasts support human hematopoietic progenitor cells in in vitro bone marrow cultures. Blood 1996; 87: 518-524.
11. Yamashita YM, Fuller MT, Jones DL. Signaling in stem cell niches: lessons from the Drosophila germline. J Cell Sci 2005; 118: 665-672.
12. Kimble J, Crittenden SL. Controls of germline stem cells, entry into meiosis, and the sperm/oocyte decision in C. elegans. Annu Rev Cell Dev Biol 2007; 23: 405-433.
13. Calvi LM, Adams GB, Weibrecht KW, Weber JM, Olson DP, Knight MC et al. Osteoblastic cells regulate the haematopoietic stem cell niche. Nature 2003; 425: 841-846.
14. Zhang J, Niu C, Ye L, Huang H, He X, Tong WG et al. Identification of the haematopoietic stem cell niche and control of the niche size. Nature 2003; 425: 836-841.
15. Kiel MJ, Yilmaz OH, Iwashita T, Yilmaz OH, Terhorst C, Morrison SJ. SLAM family receptors distinguish hematopoietic stem and progenitor cells and reveal endothelial niches for stem cells. Cell 2005; 121: 1109-1121.
16. Sugiyama T, Kohara H, Noda M, Nagasawa T. Maintenance of the hematopoietic stem cell pool by CXCL12-CXCR4 chemokine signaling in bone marrow stromal cell niches. Immunity 2006; 25: 977-988.
17. Lapidot T, Dar A, Kollet O. How do stem cells find their way home? Blood 2005; 106: 1901-1910.
18. d mouse. Cell Tissue Kinet 1974; 7: 89-98.
19. Adams GB, Chabner KT, Alley IR, Olson DP, Szczepiorkowski ZM, Poznansky MC et al. Stem cell engraftment at the endosteal niche is specified by the calcium-sensing receptor. Nature 2006; 439: 599-603.
20. Adams GB, Martin RP, Alley IR, Chabner KT, Cohen KS, Calvi LM et al. Therapeutic targeting of a stem cell niche. Nat Biotechnol 2007; 25: 238-243.
21. Arai F, Hirao A, Ohmura M, Sato H, Matsuoka S, Takubo K et al. Tie2/Angiopoietin-1 signaling regulates hematopoietic stem cell quiescence in the bone marrow niche. Cell 2004; 118: 149-161.
22. Matrosova VY, Orlovskaya IA, Serobyan N, Khaldoyanidi SK. Hyaluronic acid facilitates the recovery of hematopoiesis following 5-fluorouracil administration. Stem Cells 2004; 22: 544-555.
23. Dalerba P, Cho RW, Clarke MF. Cancer stem cells: Models and concepts. Annu Rev Med 2007; 58: 267-284.
24. Joyce JA. Therapeutic targeting of the tumor microenvironment. Cancer Cell 2005; 7: 513-520.
25. Calabrese C, Poppleton H, Kocak M, Hogg TL, Fuller C, Hamner B et al. A perivascular niche for brain tumor stem cells. Cancer Cell 2007; 11: 69-82.
26. Anderson KC. Targeted therapy of multiple myeloma based upon tumor-microenvironmental interactions. Exp Hematol 2007; 35: 153-162.
27. Jin L, Hope KJ, Zhai Q, Smadja-Joffe F, Dick JE. Targeting of CD44 eradicates human acute myeloid leukemic stem cells. Nat Med 2006; 12: 1167-1174.
28. Krause DS, Lazarides K, von Andrian UH, Van Etten RA. Requirement for CD44 in homing and engraftment of BCR-ABL-expressing leukemic stem cells. Nat Med 2006; 12: 1175-1180.
29. + cells enhances their engraftment of nonobese diabetic/severe combined immunodeficiency mice. Stem Cells Dev 2007; 16: 347-354.